Search - tctmd.com

Displaying 201 - 220 of 485

Sort: Relevancy | Date

News Daily News

FDA Approves TriClip TEER Device for Tricuspid Repair

L.A. McKeown

April 02, 2024

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

News Daily News

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Michael O'Riordan

March 15, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

Presentation THT Abstracts 2024

Association Between Frailty and Outcomes of Transcatheter Edge-to-Edge Repair in Functional Mitral Regurgitation: Results from the COAPT trial

Presenter: Charles Sherrod

March 04, 2024

Presentation THT Abstracts 2024

Role of Invasive Exercise Hemodynamics in Symptomatic Secondary Mitral Regurgitation Prior to Transcatheter Edge-to-Edge Repair

Presenter: Bassim El-Sabawi

March 04, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

Michael O'Riordan

February 13, 2024

News Daily News

TAVI Proficiency Doesn’t Spell Success for M-TEER at Large US Sites

Michael O'Riordan

February 13, 2024

News Daily News

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

Michael O'Riordan

February 09, 2024

News Daily News

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

L.A. McKeown

February 02, 2024

Presentation Miami Valves 2024

Mitral Transcatheter Edge-to-Edge Repair in Cardiogenic Shock: A Systematic Review and Meta-Analysis

Presenter: Fabricio Malaguez Webber

February 01, 2024

News Daily News

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

Michael O'Riordan

January 25, 2024

News Opinion Off Script

My Hopes for Cardiology in 2024: More Honesty, Humility, and Collaboration

Benoy Shah, MBBS, MD(Res)

January 24, 2024

News Daily News

Top Structural Heart News of 2023

Todd Neale

January 02, 2024

News Conference News PCR London Valves 2023

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

Shelley Wood

November 28, 2023

News Conference News PCR London Valves 2023

For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE

Shelley Wood

November 20, 2023

News Conference News TCT 2023

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Yael L. Maxwell

November 02, 2023

News Conference News TCT 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Yael L. Maxwell

October 30, 2023

News Conference News TCT 2023

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Michael O'Riordan

October 26, 2023

Advertisement

FDA Approves TriClip TEER Device for Tricuspid Repair

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Debating the Role of T-TEER in the Sickest Patients

Association Between Frailty and Outcomes of Transcatheter Edge-to-Edge Repair in Functional Mitral Regurgitation: Results from the COAPT trial

Role of Invasive Exercise Hemodynamics in Symptomatic Secondary Mitral Regurgitation Prior to Transcatheter Edge-to-Edge Repair

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

TAVI Proficiency Doesn’t Spell Success for M-TEER at Large US Sites

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

Mitral Transcatheter Edge-to-Edge Repair in Cardiogenic Shock: A Systematic Review and Meta-Analysis

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

My Hopes for Cardiology in 2024: More Honesty, Humility, and Collaboration

Top Structural Heart News of 2023

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content